chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had a headache, chills. fever, cough that lasted a month, sore throat. I took a home COVID-19 test that came back negative I went to urgent care who gave me a Z-PAK. Benzonatate and inhaler they did not help and the inhaler made me feel lightheaded. A week later I went to another clinic who prescribed benzonatate and told me to continue using my inhaler. This did not help either. A week later I went to the emergency room, they did a chest x-ray that showed nothing. I was told they could do nothing for my chronic cough I would need to learn to live with it.
Shingles; Information has been received regarding a case in litigation, referring to a male pt of unknown age. Information regarding the pt's pertinent medical history, concurrent conditions, known allergies and concomitant medications was not provided. In or about 2017, the pt was vaccinated with zoster vaccine live (ZOSTAVAX) (route of administration, strength, dose, lot # and expiration date were not provided) by a healthcare provider at a pharmacy for the long-term prevention of shingles and/or zoster-related conditions. On an unknown date, the pt was treated at a hospital for shingles. As a direct and proximate result of the pt's use of the zoster vaccine live (ZOSTAVAX) vaccine, had and would continued to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, included but not limited to medical losses and costs which included care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. At the time of the report, the outcome of herpes zoster was reported as not recovered. The lawyer considered herpes zoster to be related to zoster vaccine live (ZOSTAVAX).
J96.00 ACUTE RESPIRATORY FAILURE 2/14/2021 CHF EXACERBATION, UNSPECIFIED J96.00 ACUTE RESPIRATORY FAILURE 2/14/2021 CHF (CONGESTIVE HEART FAILURE), UNSPECIFIED J96.00 ACUTE RESPIRATORY FAILURE 2/14/2021 CELLULITIS
Client c/o dizziness, stated he needed to sit down and just fell backward to the floor. He was pale, clammy and alert, oriented to person place and times. State he remembers being dizzy. Denies any pain. No apparent injury noted to head denies any H/A. BP 130/80, pulse 60, Resp. 18 feet elevated on chair. @0945 then @9:50 BP180/80 pulse 70 Resp. 18 EMS here color improving  BP 128/70, BLD sugar 101 per EMS. Assisted up to standing postion, denies any problems ambulatory with any problems. Client refused transport to hospital. Released by EMS. Staff allowed he to sit for 20 minute offered water and crackers. Released to drive home when ready.
she noticed that her 'under arm is tender and sore"; This is a spontaneous report from a contactable consumer (patient) or other non hcp. A female patient of an unspecified age received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number was not reported) via an unspecified route of administration on 22Apr2021 as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. Patient stated that she received her second vaccine dose on Thursday, 22Apr2021 and on 23Apr2021 (Friday) she noticed that her under arm is tender and sore. Stated that she does not see anything on her arm but there was a tender a sore area, not at the injection site. Reporter stated that she had read the most common side effects but asks if we have heard of someone having soreness and tenderness to the under arm that is tender to touch. The outcome of the event she noticed that her under arm is tender and sore was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Within 5 minutes of administration, pt reported feeling dizzy and became sweaty and clammy. She took her BP med this morning  and admits that she was overdue to eat. After consuming peanut butter crackers and a bottle of water, her symptoms had subsided and she reported feeling 100% better.
Leg pain and lower back all on the right-side. Causes me to limp. Starts 2-3 days after every vaccine. This time worse than all previous vaccines.  It takes about almost 2 weeks before it goes away.
i had severe lymph nodes swelling pain under my eye. I went to the doctor to get an ultrasound because i had pain but they didn't find anything. I had flare up because i have thyroid disease my eye swelled up and had a significant dryness. i went to the eye doctor and he ordered blood test
This was reported to me by RN.  Patient received 2nd Moderna vaccine on the 21st day interval after receiving the first dose of Moderna Covid vaccine on 2/15/21.
12/18 vaccination 9am about 12 Hours later, experienced nausea.  12/19 nausea, body aches, fatigue, severe HA. Took ibuprofren and Tylenol intermittingly. Lasted 8 days.  Urgent care on 12/22; Covid test
fine rash noted Saturday evening on arms and chest w /slight itchiness; occasional itchiness on Friday w/ no rash noted/fine rash noted Saturday evening on arms and chest w /slight itchiness; face felt prickly and itchy; face felt prickly and itchy; This is a spontaneous report from a contactable nurse (the patient).  A 54-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot EH9899, via Intramuscular route of administration in right arm, on 17Dec2020 at 16:30, at single dose for COVID-19 immunization. The vaccine was administered at Hospital Facility. The patient did not receive other vaccine in four weeks. The patient medical history included sinus infections and past history of mono. The patient had allergy to kindest care hand sanitizer, alcare and eucerine hand cleanser. The patient's concomitant medications included ascorbic acid, zinc oxide (IMMUNE BOOST OTC). The patient on 17Dec2020 at 17:15, felt face prickly and itchy. No airway distress. Benadryl was administered at 22:30 that night. Physician was made aware. Occasional itchiness was observed on 18Dec2020. No rash noted. Fine rash was noted on 19Dec2020 evening on arms and chest with slight itchiness. No Covid-19 was diagnosed prior vaccination. Covid-19 was not tested. The outcome of the events was resolving.
Information has been received from a registered pharmacist concerning her son, a 14 month old male with no pertinent medical history and no known drug reactions/allergies who in July 2008, was vaccinated subcutaneously with the 0.5ml dose of VARIVAX (Merck). There was no concomitant medication. About a week after the vaccination, the patient developed a mild case of chicken pox. Subsequently, the patient recovered from chickenpox. Unspecified medical attention was sought. No further information is available.
PATIENT ARRIVED AT PHARMACY TO RECEIVE A TDAP VACCINE DUE TO RELATIVE HAVING BABY.  AFTER INQUIRING ABOUT PAST EXPERIENCE AND VACCINES AND PATIENT REPORTING NO PROBLEMS WITH VACCINES IN PAST I ADMINISTERED THE VACCINE.  ABOUT 5 TO 10 MINUTES LATER SHE ARRIVED BACK AT THE PHARMACY COMPLAINING OF CHEST PAIN.  I TOOK HER BACK TO THE IMMUNIZATION ROOM TO MONITOR HER.  I IMMEDIATELY TOOK HER BLOOD PRESSURE (168/103) INQUIRED ABOUT HER HISTORY OF VACCINES AGAIN, FOOD SHE HAD EATEN THAT DAY, & HEALTH HX.  AFTER LEARNING SHE HAD BEEN DIAGNOSED WITH AFIB I RECOMMENDED WE CALL 911, SHE EVENTUALLY AGREED (SHE WAS STILL IN PAIN AND SCARED).  WE CONTACTED 911 & HER HUSBAND. EMSA RESPONDED AND TRANSPORTED HER TO HOSPITAL
Patient stated after about 15 minutes after receiving vaccine that her face felt numb, she said it feels like it spread from her arm where the shot was given up into her neck and into her face which was numb and tingly
Patient received vaccine at 10:00 AM. At 3:00 pm that same day he began experiencing aches from head to toe in all joints and began shivering. Wife called pharmacy, was advised to see MD. The MD sent him to the E.R. was given TORADOL injection (per wife) and sxs resolved in 1/2 hour.
I started getting a cough, sinus congestion, nasal mucus membrane irritation, then I lost my sense of smell and taste for a couple of days. I have lingering sinus infections, ear blockage, and a cough. I did not have a fever. I did a Covid home test on 01/29/2022 and it tested positive. I only took Advil, cough syrup, and Benadryl for a couple of days. I would say I am 80% recovered.
she pulled air into the syringe and injected the air and liquid into the vial/had an issue drawing the vaccine out of the vials/she devised her own way of doing it; This case was reported by a pharmacist via other manufacturer and described the occurrence of wrong technique in product usage process in a patient who received Rabies NVS (RabAvert) (batch number ARBA731A, expiry date September 2023) for prophylaxis.   On 12th August 2020, the patient received RabAvert 1 ml. On 12th August 2020, unknown after receiving RabAvert, the patient experienced wrong technique in product usage process. On an unknown date, the outcome of the wrong technique in product usage process was unknown.  Additional information was received as follows: Age at vaccination was not applicable for this report. The Pharmacist reported having questions regarding the reconstitution of rabies vaccine. The pharmacist further added of giving the vaccine to a family of 4 last night and that the nurse had an issue drawing the vaccine out of the vials leading to wrong technique in product usage process. She had one of the old products and it went fine, but the 3 new ones were difficult with the withdrawal from the vial.  The first vial the nurse could not get all of the vaccine out and just discarded it as she felt she contaminated it. The next one she devised her own way of doing it, and she pulled air into the syringe and injected the air and liquid into the vial which led to wrong technique in product usage process. The pahrmacist also informed that as per PI, we should never leave a needle in the vial when we reconstitute. The pharmacist further stated that nurses think the vial is different, but the she was not sure because she did not have any of the other lot to compare. Pharmacist did not have any of the patient information while on call. Upon follow up with the pharmacist, pharmacist stated that they have since administered the vaccine and followed the directions and it worked just fine. This case was linked to case US2020AMR163372 and US2020AMR163382 by same reporter. This case was for patient 2 of 3.   Following internal review it was determined that initial reciept date was 13th August 2020 for follow up 1 and 17th August 2020 for follow up 2 and 3, which is earlier than initially reported.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR163372: US-GLAXOSMITHKLINE-US2020AMR163382:
Patient started to have reactions minutes after MMR vaccine was administered to her at family medicine on 7/24/2023. She became dizzy, clammy and proceeded to vomit.
Inappropriate schedule of vaccine; This non-serious case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 59-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on 19th October 2021), Flulaval and Shingrix (received 1st dose on 19th October 2021).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: Inappropriate schedule of vaccine). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 10-NOV-2022 The reporter was patient's husband. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The reporter also states the wife received a Flulaval 21/22 SYR (no further information provided) at the same time. No lot number expiry date , route of administration, or location of administration was provided for either vaccine. The patient was on the phone in the background on the call but did not speak directly with the patient. The reporter consented to follow up.
Client's mother called on 02/26/2016 at 3:00 PM to report that the day before she had picked up client from school since he was vomiting and had a fever of 102 degrees F. Client's mother reported that Tylenol was not helping to relieve fever. Client's mother was instructed to seek medical attention. I spoke on the phone with client's mom on 3/7/2016 and she reports that they did not seek medical attention, but client is now feeling better. Illness lasted 4-5 days total. Vomiting and fever were the only symptoms reported.
Before the administration of Pfizer COVID vaccine it was diluted by one of the pharmacists on duty, however she did not dilute it with the correct amount of diluent. The proper dilution amount is 1.8 ml of diluent added to the vial, but it was discovered that the vial was only diluted with 0.8 ml. The error was discovered, after 3 doses had been administered. While determining the number of doses remaining in the vial it was discovered that only 1 more dose remained instead of 3. This was caused by too little diluent being added resulting in each vaccine dose to be A higher concentration than recommended.
Patient was initially admitted to the medical COVID floor.  He was initiated on remdesivir and dexamethasone.  He was transferred to the ICU on 8/17/2021 due to worsening respiratory status and need for noninvasive ventilatory support.  Due to his worsening renal function, remdesivir was discontinued as it is known to potentially contribute to worsening renal function.  He was initiated on CRRT on 8/18/2021.  Patient's respiratory status continued to worsen and he was intubated on 8/21/2021.  Unfortunately, over the next several days, patient's condition worsened overall.  He was unable to be weaned from high ventilatory support needs.  CRRT was optimized to insure diuresis to try to optimize ventilator conditions.  Unfortunately, on the morning of 8/25/2021, the patient did suffer a sudden cardiac arrest.  CPR and ACLS interventions were initiated without success.  Nursing staff was in contact with the patient's family via telephone during the cardiac arrest and resuscitation.  They did advise that they did not want to continue ongoing resuscitative efforts and further efforts were terminated.  Unfortunately, patient did pass on the morning of 8/25/2021 at 0150 hr
RECEIVED 15 MONTH SHOTS 4 DAYS AGO- STARTED WITH SWELLING OF LEFT LEG. NO TEMPERATURE. CAME TO OFFICE- 1" X 1.25" BUMP WITH SWELLING AND REDNESS MEASURED. SYMPTOMATIC TREATMENT ADVISED.
Patient was given the Janssen covid vaccine and after he had sat down in the waiting are he fainted.  time was 12:39 pm Friday, 4/9/21. We called EMS and code white at that time.  Patient was unresponsive for a few seconds but woke up quickly.  When we asked about any reactions to previous vaccine patient stated he had no reactions.  After talking to him once he was feeling better, he did mention that this has happened in the past when his blood sugar was low.  We gave cool compress and patient refused services from EMS.  We also offered water and store management offered orange juice.  We also advised him to stay for an additional 30 minutes for observation.
About 4 hours after vaccine - started to have a headache: 3 out of 10; took a couple of Motrin (200 mg) and rest; 4 hours later - headache worsened (not migraine though); hot flashes- took blood pressure : 137/85 (my usual is 110/80 - normal) and took another motrin and hydrated. 21:00 pm QR Code - CDC Info number - 800 number called them(doctor was out of town)-called again the next day, as I was concerned about  @hypertension. Blood pressure second day: (150/90 went up to) ; CDC couldn't give medical advice - if it gets worse go see DR; on second day got up to 160/100 - took another Motrin and rested. Stayed in bed for two days. Third day at 4:00 am - no headache that third morning - blood pressure was back to normal. Headache came and went for next five days on different side of head.
She slept for over 24 hours, completely lethargic when waking for feeds.  Following her waking up, she screamed for about 2 weeks.  Inconsolable screaming.  Today is 2/11/15 and just in the last couple of days has she gone back to her calm self.
Pt was vaccinated on 12/30.  Reported adverse event starting 1/6 with itchiness at injection site and a slightly painful, raised area.  There was also a peanut-sized knot under the skin.  On 1/7, the itchiness resolved and there was no knot, but the site remained tender and slightly raised.
Product Complaint; leaked out from lock and syringe; leaked out from lock and syringe; This case was reported by a other health professional via call center representative and described the occurrence of incomplete dose administered in a 17-year-old female patient who received Men B NVS (Bexsero) (batch number ABXB37AA, expiry date 31st July 2022) for prophylaxis. This case was associated with a product complaint.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 3rd February 2022, the patient received the 2nd dose of Bexsero (intramuscular) 1 dosage form(s) and Bexsero Pre-Filled Syringe Device. On 3rd February 2022, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced incomplete dose administered and syringe leak. On an unknown date, the patient experienced pharmaceutical product complaint. On an unknown date, the outcome of the incomplete dose administered, syringe leak and pharmaceutical product complaint were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The reporter reported that, she was administering a dose of Bexsero from a pre filled syringe and the liquid leaked out from between the luer lock and syringe barrel when she depressed the plunger to give the dose and the patient did not get the dose which led to incomplete dose administered. The defect was discovered in the process of administering and the needle was in the patient but there was a leak and unknown if any went into the patient.  The leak was between luer lock device and the syringe barrel.  The needle was put on immediately before administration.  The size of gauge needle used was 25G x 1 inch.  blister and/or carton was not damaged.  No visible luer lok damage was noted.  The needle which was used was available and would be returned with product.  No apparent damage or breakage was noted on the syringe barrel. No picture would be emailed in.  Suspect syringe would be returned to GlaxoSmithKline by healthcare professional.  The reporter would call back with information on the patient to whom the vaccine was administered because she did not have that information available.  Consent did not ask because the healthcare professional was reporter and the patient was unknown.
Severe, knife like pain near injection site with pain into axilla - group of 4 pustules formed - delayed reaction.
STOMACH PAIN; NUMBNESS/COULD NOT FELT LEGS OR ARMS; TINGLING; HEADACHE; This spontaneous report received from a patient concerned a 52 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.  The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042a21a, expiry: 21-JUN-2021) dose was not reported with frequency 1 total administered on 01-APR-2021 to right arm for prophylactic vaccination. No concomitant medications were reported.  On 24-MAY-2021, after vaccination the patient had tingling in her legs and hands, she had headaches, sharp pain in her stomach and went to the hospital and could not felt her legs or arms when she woke up. Then she came home and she could not felt her upper part of her left leg and it was kind of numb. The patient was hospitalized for events on 24-MAY-2021 for 1 day and got discharged on 25-MAY-2021. The action taken with Covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the numbness/cant feel legs or arms, tingling, stomach pain and headache was not reported. This report was serious (Hospitalization Caused / Prolonged).; Sender's Comments: V0: 20210740945-Covid-19 vaccine ad26.cov2.s-Stomach pain, Numbness/could not feel legs or arms, Tingling. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).  V0: 20210740945-Covid-19 vaccine ad26.cov2.s-Headache. This event(s) is labeled per RSI and is therefore considered potentially related.
Last night (April 1), my lower hips and back started hurting (9/10). This morning when I woke up the injection site is raised, red, and warm to the touch.
Fever that got up to 102.2 F,  Aches, Pain, SOB, Malaise, Fatigue
Hours after receiving Td patient developed "high fever", pain over entire body.  Was seen in ER and told had very low b/p.  Also told she had reaction to vaccine.  Not hospitalized.  Reports fever and pain lasted for 4 days.
no additional adverse eents reported; she gave a dose of PROQUAD today that expired on 07-APR-2021; This spontaneous report was received from an other health professional and refers to a patient of unknown age and gender. The patient's concurrent conditions, medical history, concomitant medications, drugs reactions or allergies were not provided.  On 27-APR-2021, the patient was vaccinated with expired measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) lot # S031884 with expiration date 07-APR-2021(dose, strength, route of administration were not provided) for prophylaxis. The vaccine was properly stored up through the time of vaccination. No additional adverse events reported.